Dr. Nachi Gupta is the former Chief Innovation Officer at Kriya Therapeutics, a leading AAV gene therapy company focused on ophthalmology, neurology, and metabolic diseases. He is also a board certified emergency physician practicing in California. Nachi previously worked at Brevan Howard Asset Management, focusing on G10 FX, commodities, emerging markets, and U.S. economics. Prior, he spent time on the computational and scientific teams for ballistic missile defense at MIT Lincoln Laboratory and Hanscom Air Force Base.

Nachi completed his medical residency at Mount Sinai Hospital and Elmhurst Hospital Center in New York City. He holds an M.D. from Brown University, a Ph.D. in Mathematics and Computer Science from Oxford University, and graduate and undergraduate degrees in Mathematics, Computer Science, Economics, and Telecommunications from the University of Pennsylvania.